Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04811521 · ClinicalTrials.gov registry record · NA
Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room
A NA study of Generalized Anxiety Disorder and Chest Pain, sponsored by Indiana University.
- Active
- Registry status
- NA
- Development phase
- 375
- Enrollment target
- 5
- Study locations
NCT04811521: Active NA study of Generalized Anxiety Disorder and Chest Pain, sponsored by Indiana University.
NCT04811521 is a NA study of Generalized Anxiety Disorder and Chest Pain that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 375 participants, above the 207-participant average among 48 other Generalized Anxiety Disorder trials with a reported enrollment target (81% higher). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04811521, a NA study of Generalized Anxiety Disorder and Chest Pain, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 375 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this research is to compare the benefits and risks of three anxiety treatments that are pragmatic, graduated in the level of resource intensity, and have demonstrated efficacy and feasibility for real world adoption.
Conditions Studied
Interventions
- BEHAVIORAL Primary care follow-up
- BEHAVIORAL Online Self-Administered Anxiety Management Program plus Peer Support Guidance
- BEHAVIORAL Therapist-Administered Cognitive Behavioral Therapy
Study Locations (5)
Indiana
- Indiana University Health West Hospital - Avon
- Indiana University Health North Hospital - Carmel
- Indiana University Health Saxony Hospital - Fishers
- Indiana University Health Methodist Hospital - Indianapolis
- Indiana University Health Ball Memorial Hosptial - Muncie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2025-08-17 |
| Phase | NA |
What the registry record for NCT04811521 still lists
NCT04811521 is an interventional study that assigns participants to a tested intervention. The registered 375 participants enrollment target is mid-sized for trials with a published cap, above the 207-participant average among 48 other Generalized Anxiety Disorder trials with a reported enrollment target (81% higher).
The record links to 3 conditions, with Generalized Anxiety Disorder appearing as the primary indexed condition, and to 3 interventions - of which Primary care follow-up is the first listed.
NCT04811521 lists 5 locations in 1 state (Indiana).
Frequently Asked Questions
What is clinical trial NCT04811521 about?
NCT04811521 is a clinical study titled "Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room". The goal of this research is to compare the benefits and risks of three anxiety treatments that are pragmatic, graduated in the level of resource intensity, and have demonstrated efficacy and feasibility for real world adoption.
What is the current status of trial NCT04811521?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 375 participants. The study started on 2021-04-01. Estimated completion is 2025-08-17.
What conditions does trial NCT04811521 study?
This clinical trial studies the following conditions: Generalized Anxiety Disorder, Chest Pain, Panic.
What interventions are being tested in trial NCT04811521?
The interventions under investigation include: Primary care follow-up (BEHAVIORAL), Online Self-Administered Anxiety Management Program plus Peer Support Guidance (BEHAVIORAL), Therapist-Administered Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04811521?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04811521 being conducted?
This trial has 5 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Generalized Anxiety Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04811521's enrollment target sits among peer trials
375 9th of 48 higher than 40 of 48 other Generalized Anxiety Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Generalized Anxiety Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
-
Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
RECRUITING · NA
-
Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD)
RECRUITING · NA
-
Massage for GAD: Neuroimaging and Clinical Correlates of Response
RECRUITING · NA
-
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RECRUITING · NA
-
Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03686124 · 375 participants · Phase 1
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- NCT04059172 · 375 participants · Early Phase 1
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
- NCT04134923 · 375 participants
Imaging Biomarkers in Preclinical and Symptomatic AD
- NCT04569747 · 375 participants · Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI